Taylor Wessing advised Healx on its funding round. Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases based in Cambridge UK, has raised $47 million...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised the investors on Mission Zero Technologies’ Series A funding. Climate tech leader Mission Zero Technologies secured £21.8 million in Series A funding. Investors...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised AlveoGene on its complex spinout and launch investment. AlveoGene, a newly established UK gene therapy company, has successfully completed a complex spinout from...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Bitkraft Ventures on their participation in this funding round. Scriptic, formerly known as ElectricNoir, has announced that it has raised $5.7 million in...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised investment bank Panmure Gordon on the matter. Panmure Gordon, as Nominated adviser and broker, made a £6m placing for globally focused biopharmaceutical group,...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised New Science Ventures on the deal. US deep-tech investor, New Science Ventures, acted as lead investor on Paragraf’s $60 million Series B funding round....
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Placid0 on the deal. Placid0 has been acquired by innovative eyecare brand, WALDO. Placid0 has created EASY, an eye assessment system mobile application,...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, thorugh its Series B financing, raised a...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised the founders of Telensa Holdings Ltd on the deal. Telensa Holdings Ltd., a UK-based expert in wireless monitoring and control systems for smart...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Cambridge Epigenetix on the deal. Temasek led the round with participation from new investors including Third Point and existing investors such as GV,...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Qubit on the deal. Qubit, a leader in AI-powered personalisation tech for merchandising teams based in London, has been acquired by Coveo, a...
You must be a Standard 1 Year member to access this content.
